Hummus (HUM) news

Ambea closes Humana offer with 97.99% acceptance

UBS raises Humana's target price to $495

Humana's JV With BlackRock to Improve Financial Flexibility, Truist Says

UnitedHealth Raises Full-Year Earnings Outlook Following Third-Quarter Beat

BUZZ—U.S. Stock Market Updates—Humana, Symbotic, JPMorgan, Visa

BUZZ - BlackRock profits from clinic joint venture agreement with Humana

Humana Forms Joint Venture With BlackRock for 150 Senior Care Clinics

HUMANA <HUM.N>: MIZUHO RAISES TARGET PRICE TO $495 FROM $468

Humana sets third-quarter results release, earnings call

HUMANA INC. <HUM.N>: UBS RAISES TARGET PRICE TO $495 FROM $405

Sector Update: Healthcare Stocks Higher Pre-Bell Monday

Sector Update: Healthcare

Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Monday as Investors Weigh Oil, Earnings

HUMANA <HUM.N>: RAYMOND JAMES RAISES TO OUTPERFORM FROM MARKET PERFORM

HUMANA <HUM.N>: TRUIST SECURITIES RAISES TARGET PRICE TO $475 FROM $415

Raymond James Upgrades Humana to Outperform From Market Perform, Price Target is $520

DataMeds AI Says Helomics' ChemoFx Test Receives Humana Medicaid Coverage Policy; Shares Rise Pre-Bell

DataMeds AI unit Helomics wins Humana Medicaid coverage for ChemoFx gynecologic cancer assay

HUMANA <HUM.N>: OPPENHEIMER RAISES TARGET PRICE TO $525 FROM $475

Oppenheimer raises Humana's target price to $475

Update: Nasdaq Rises to Notch Fourth Weekly Gain; Crude Prices Stabilize

05:08 PM EDT, 10/09/2026 (MT Newswires) -- (Updates with market moves at the end of the day, and other changes, if any.) The Nasdaq Composite rose Friday, securing its fourth straight weekly gain, while crude prices were little changed. The index climbed 0.6% to 27,366.17. The Dow Jones Industrial Average advanced 0.8% to 51,654.95, while the S&P 500 added 0.6% to 7,811.54. Except for communications services and energy, all sectors ended in the green, led by real estate. This week, the Nasdaq gained 0.6%, extended its winning streak to a fourth consecutive week. The S&P 500 and the Dow logged weekly increases of 1.2% and 0.9%, respectively. "Equity markets bounced back this week with little in the way of major market-moving data, and as Treasury yields paused their relentless run higher," BMO Senior Economist Robert Kavcic wrote in a note. US consumer sentiment fell to a five-month low in October as the one- and five-year inflation expectations reached their highest levels since May, preliminary results of a University of Michigan survey showed Friday. "While year-ahead expectations for personal finances and business conditions crept up slightly, buying conditions for durables plummeted amid high prices and borrowing costs," Surveys of Consumers Director Joanne Hsu said. "Frustration over cost-of-living continues to mount, as consumers across the political spectrum believe that the trajectory of the economy has weakened since the beginning of the year." Markets are pricing in a nearly 83% probability that the Federal Reserve will keep its benchmark rate steady later this month, according to the CME FedWatch tool. West Texas Intermediate crude slipped 0.1% to $91.42 a barrel in Friday late-afternoon trade, while Brent was little changed at $104.24. Both benchmarks were up for the week, with Brent on track for its third consecutive weekly increase. President Donald Trump said Friday that Russian President Vladimir Putin agreed to supply diesel to the US and global markets. The 10-year US Treasury yield was up 1.1 b

Humana Inc. Stock Rises 11.6%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights. Shares of Humana Inc. climbed 11.6% to $431.87 on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,811.54 and the Dow Jones Industrial Average rising 0.8% to 51,654.95. The stock's rise snapped a two-day losing streak. Humana Inc. hit a new 52-week high, surpassing its previous peak of $428.88, which the company reached on July 16th. The stock outperformed some of its peers, as UnitedHealth Group Inc. rose 2.3% to $379.30, Elevance Health Inc. rose 2.9% to $412.70, and Chubb Ltd. fell 0.75% to $341.20. Trading volume totaled 5.0 million, compared to the 50-day average of 1.2 million. Data source: Dow Jones Market Data, FactSet (END) Dow Jones Newswires October 09, 2026 16:33 ET (20:33 GMT)

Sector Update: Healthcare Stocks Gain Late Afternoon

03:57 PM EDT, 10/09/2026 (MT Newswires) -- Healthcare stocks rose late Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 2.8%. In corporate news, Humana (HUM) shares surged 12% after it affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share. Humana also said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." Shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 12%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 2.6%, 17% and 5.3%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped 10% and 5.6%, respectively. Brookdale Senior Living (BKD) shares were falling 5.2%. The company's weighted average occupancy rose sequentially but at a slower rate in September, resulting in Q3 occupancy coming in "slightly below" estimates, RBC Capital Markets said in a note emailed Friday. TRex Bio (TRXB) shares were up 1.4% after the company's Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.

Humana Shares Surge Following Significant Medicare Advantage Star Ratings Improvement

03:51 PM EDT, 10/09/2026 (MT Newswires) -- US health insurance and managed care stocks were mostly advancing Friday, with Humana (HUM) surging following its industry-leading star ratings improvement in the 2027 Medicare Advantage plans. Humana Chief Executive Jim Rechtin said that 95% of the health insurer's Medicare Advantage, or MA, members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027. That's significantly higher from plans for the previous year, according to analysts at Oppenheimer and Truist Securities. "Our 2027 stars results...approach the highest star ratings Humana has ever achieved, with a member weighted star rating of 4.17," Rechtin said in prepared remarks posted on the company's website Friday. Humana logged "significant performance improvement" across all measure categories, the company said in a statement. CMS rates MA and Part D plans on a five-star scale annually based on measurements of quality of care, member experience and customer service. "Humana's recovery is impressive given the speed and magnitude of the turnaround," Oppenheimer said in a note to clients. "Overall, we estimate a $3.6 (billion) revenue impact in 2028 (versus) the estimated 2027 exposure." Humana shares were up 12% in late-afternoon trade, taking the stock's year-to-date gains to 70%. Clover Health Investments (CLOV) jumped 5.9%, while Elevance Health (ELV), Centene (CNC), UnitedHealth Group (UNH), and Molina Healthcare (MOH) were also higher. Alignment Healthcare (ALHC) slid 12%, while CVS Health (CVS) edged down 0.7%. Separately, Humana said Friday it continues to expect full-year adjusted earnings of at least $9 a share, according to a regulatory filing. Analysts in a FactSet poll are looking for $9.16. CVS' Aetna said that more than 69% of its MA members are in 2027 plans rated four stars or higher, while Alignment Healthcare said six of seven eligible MA contracts earned at least four stars. Clover said its Preferred Provider Organization MA plans

Update: US Equity Indexes Rise Amid Strong Gains in Mega-Cap Technology

02:10 PM EDT, 10/09/2026 (MT Newswires) -- (Updates with index/price moves, macroeconomic data, and company/geopolitical news from the first paragraph.) US equity indexes rose amid a broad-based rally that lifted all sectors and strong gains in mega-cap technology names, as investors seemingly whistled past a bear steepening in the yield curve. The Nasdaq Composite climbed 0.6% to 27,346.2, the S&P 500 advanced 0.6% to 7,808.5, and the Dow Jones Industrial Average marched 0.8% higher to 51,632.1. Healthcare, real estate and consumer discretionary led the gainers. Among stocks with market capitalization exceeding $200 billion, as many as six of the top 10 were technology names, according to data compiled by Finviz. Oracle (ORCL) led the gainers in this mega-cap category, up 4.8%. In economic news, the University of Michigan's preliminary consumer sentiment index declined to 46.3 in October from 48.1 in September, versus the 47.6 expected in a Bloomberg-compiled survey. Respondents pegged one-year inflation expectations at 4.7%, up from 4.6% in the previous month, while the five-year figure increased to 3.5% from 3.4%. "Overall, sentiment for lower-income consumers and those with smaller stock portfolios dropped steeply this month, groups that have fewer resources to weather increases in prices," Michigan said. The CME FedWatch tool showed that the probability of the Federal Reserve leaving its target rate unchanged in October was 81% on Friday afternoon. However, the market sees a 71% likelihood that the Fed will raise its target rate by 25 basis points in December and assigns a 45% probability of another move higher of the same magnitude in March to ease inflation back to the Fed's 2% target. Term premium, or the extra payout for the risk of investing in 10-year Treasuries instead of just rolling over short-dated securities for the same amount of time, hit 1.2 percentage points this week, up from 0.68 percentage points a year ago, according to data compiled by Bloomberg. The move higher reflects concerns about th

Sector Update: Healthcare Stocks Gain Friday Afternoon

01:50 PM EDT, 10/09/2026 (MT Newswires) -- Healthcare stocks rose Friday afternoon, with the NYSE Healthcare Index up 1.2% and the State Street Health Care Select Sector SPDR ETF (XLV) adding 1.6%. The iShares Biotechnology ETF (IBB) climbed 3%. In corporate news, Humana (HUM) shares surged nearly 12% after it affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share. Humana also said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." Shares of Moderna (MRNA) and other vaccine developers rose after The New York Times reported that the US National Institutes of Health is part of a public-private partnership to accelerate the development of cancer vaccines. Moderna shares jumped 12%. Merck (MRK), Novavax (NVAX) and BioNTech (BNTX) shares were up 3%, 15% and 5.2%, respectively. Vaxcyte (PCVX) and Vir Biotechnology (VIR) shares popped nearly 9% and 6%, respectively. TRex Bio (TRXB) shares were down 2.5% after the company's Nasdaq debut. The biotech company priced its initial public offering of around 8.3 million common shares at $14 apiece for gross proceeds of $116.7 million.

Humana is the 'Biggest Winner' From CMS' Medicare Advantage Star Ratings Impact on 2028 Reimbursements, Oppenheimer Says

12:46 PM EDT, 10/09/2026 (MT Newswires) -- Humana (HUM) is the "overwhelming" winner from the Centers for Medicare & Medicaid Services' Medicare Advantage Star Ratings impact on 2028 reimbursements, Oppenheimer said in a Thursday research report. CMS released Star Ratings affecting 2028 reimbursement, with 4+ Star Rating membership exposure at 71% compared with 64% a year earlier, analysts wrote. The brokerage estimated that with 95% of Humana members in 4+ Star plans, the difference will account for over $3.6 billion in revenue for the company, resulting in around $20 in EPS if not passed through to bids, according to the note. Humana's membership-weighted average Star Rating grew from 53% to 95%, driven by a rebound in the national contract, according to Oppenheimer. The brokerage said it reiterated its outperform rating on the stock and increased its price target to $475 per share from $405. Price: 434.65, Change: +47.53, Percent Change: +12.28

Top Midday Stories: Delta Shares Fall After Q3 EPS, Revenue Misses; Apple Reportedly Cuts iPhone 18 Pro Component Orders Due to Soft Demand

12:14 PM EDT, 10/09/2026 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Friday, as tech stocks took a step up. In company news, Delta Air Lines (DAL) reported Q3 adjusted earnings Friday of $1.72 per diluted share, up from $1.70 a year earlier but below the FactSet consensus analyst estimate of $1.77. Total Q3 adjusted revenue was $17.59 billion, up from $15.20 billion a year ago but below the FactSet consensus of $17.65 billion. For 2026, Delta expects adjusted EPS of $5.10 to $5.60, down from its prior estimate of $6.50 to $7.50 and compared with the FactSet expectation of $5.51. For Q4, the company expects adjusted EPS of $1.15 to $1.65 and revenue growth of around 20%. Analysts expect non-GAAP EPS of $1.43 on revenue of $17.24 billion. Delta shares were down 1.9% around midday. Apple (AAPL) has asked some suppliers to cut production of components for its iPhone 18 Pro and Pro Max models, Nikkei Asia reported Friday, citing people familiar with the matter. October orders were down by at least 15% from initial requests amid rising memory chip costs and weaker demand, the report said. Apple shares were down 1.8%. SpaceX (SPCX) said Thursday it agreed to acquire a nationwide portfolio of licenses covering up to 14 megahertz of paired spectrum in the 800 MHz band to expand Starlink Mobile's coverage in the US. The move could put pressure on wireless carriers, according to media reports. SpaceX shares were up 1.6%, while shares of AT&T (T), Verizon Communications (VZ) and T-Mobile US (TMUS) were down 9.8%, 9.9% and 12.8%, respectively. Humana (HUM) said Friday that 95% of its Medicare Advantage members are enrolled in plans with ratings of at least four stars by the Centers for Medicare and Medicaid Services for 2027, which it called a "significant improvement." CVS Health's (CVS) Aetna said over 69% of its MA members are in 2027 plans rated four stars or higher, while Alignment Healthcare (ALHC) said six of seven eligible MA contracts earned at least four stars. Humana shares we

Top Midday Gainers

12:06 PM EDT, 10/09/2026 (MT Newswires) -- Veea (VEEA) surged 67% amid heavy trading after the company said late Thursday it regained full compliance with Nasdaq's continued listing requirements. More than 68 million shares traded intraday, compared with a daily average of about 6.7 million. Humana (HUM) affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share on Friday. Oppenheimer raised Humana's price target to $475 from $405 while maintaining its outperform rating. Shares jumped 13%, with intraday trading volume rising to over 2.8 million, versus a daily average of about 1.3 million. Moderna (MRNA) and other vaccine developers' shares rose after The New York Times reported that the National Institutes of Health is part of a public-private partnership to accelerate cancer vaccines' development. Shares climbed 9%, with intraday trading volume at over 15 million, versus a daily average of roughly 18 million. Price: 6.46, Change: +2.59, Percent Change: +66.93

Update: Consumer Discretionary Helps Push US Equity Indexes Higher in Midday Trading

11:44 AM EDT, 10/09/2026 (MT Newswires) -- (Updates with index/price moves, macroeconomic data and company/geopolitical news from the first paragraph.) US equity indexes rose, with consumer discretionary leading the sector charts in midday trading Friday. The Nasdaq Composite climbed 0.5% to 27,320.1, the S&P 500 advanced 0.5% to 7,801.2, and the Dow Jones Industrial Average marched 0.5% higher to 51,501.7. All sectors except communication services and consumer staples rose. Real estate was among the biggest gainers. In economic news, the University of Michigan's preliminary consumer sentiment index declined to 46.3 in October from 48.1 in September, versus the 47.6 expected in a Bloomberg-compiled survey. Respondents pegged one-year inflation expectations at 4.7%, up from 4.6% in the previous month, while five-year inflation expectations increased to 3.5% from 3.4%. Most Treasury yields rose around midday. The two-year jumped six basis points to 4.82%, the strongest level since about mid-2024. The 10-year rate climbed 4.3 basis points to 5.27%. Front-month US West Texas Intermediate crude oil contract edged up 0.2% to $91.70 per barrel, while global benchmark Brent climbed 0.2% to $104.45 per barrel. In company news, SpaceX (SPCX) shares rose 1.6% after the rocket and satellite company agreed to acquire a nationwide low-band spectrum portfolio from investment firm Grain Management as it seeks to establish Starlink Mobile as a major US mobile carrier. AT&T (T) shares slumped 6.8%, Verizon (VZ) dropped 5.2%, and T-Mobile US (TMUS) sank 9%. All three stocks were among the S&P 500's worst performers. Humana (HUM) shares surged 12%, among the S&P 500's top gainers, after the company affirmed its full-year 2026 guidance of at least $9 in adjusted earnings per common share.